8th Edition of the event to promote India as a manufacturing hub of quality medical products in the Pharmaceutical and Medical Devices Sector
Testing supporting allergy diagnosis now accessible to more people in more communities
The Indian pharmaceutical industry includes a network of 3,000 drug companies and 10,500 manufacturing units. It is projected to reach a value of US$ 130 billion by 2030
The collaboration between CORONA and Ferring will cater to patients across India
Nous-209 has been developed using the Nouscom's viral vector platform
Biopharma can benefit from the critical enablers of innovation in the private healthcare system in India
The Research by Indian Fellow at the University has major implications for neurodegenerative disease treatments
Lebrikizumab is an investigational high-affinity and potent IL-13 inhibitor being studied in adult and adolescent patients
Cipla has recently signed an agreement to make and market the diabetes therapy Galvus and its combination brands in India from 01 January 2026.
The New State-of-Art OligoPilot 2000 solid-phase synthesizer adds cGMP manufacturing capacity to support and accelerate clinical and commercial oligonucleotide programs.
Subscribe To Our Newsletter & Stay Updated
